176 related articles for article (PubMed ID: 35109816)
1. Quantitative proteomic analysis of GnRH agonist treated GBM cell line LN229 revealed regulatory proteins inhibiting cancer cell proliferation.
Tripathi PH; Akhtar J; Arora J; Saran RK; Mishra N; Polisetty RV; Sirdeshmukh R; Gautam P
BMC Cancer; 2022 Feb; 22(1):133. PubMed ID: 35109816
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into GnRH receptor activity: role in the control of human glioblastoma cell proliferation.
Montagnani Marelli M; Moretti RM; Mai S; Müller O; Van Groeninghen JC; Limonta P
Oncol Rep; 2009 May; 21(5):1277-82. PubMed ID: 19360304
[TBL] [Abstract][Full Text] [Related]
3. Multi-Omics Data Integration and Mapping of Altered Kinases to Pathways Reveal Gonadotropin Hormone Signaling in Glioblastoma.
Jayaram S; Gupta MK; Raju R; Gautam P; Sirdeshmukh R
OMICS; 2016 Dec; 20(12):736-746. PubMed ID: 27930095
[TBL] [Abstract][Full Text] [Related]
4. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
[TBL] [Abstract][Full Text] [Related]
5. GPR17 signaling activation by CHBC agonist induced cell death via modulation of MAPK pathway in glioblastoma.
Nguyen P; Doan P; Murugesan A; Ramesh T; Rimpilainen T; Candeias NR; Yli-Harja O; Kandhavelu M
Life Sci; 2022 Feb; 291():120307. PubMed ID: 35016881
[TBL] [Abstract][Full Text] [Related]
6. LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions.
Polisetty RV; Gautam P; Sharma R; Harsha HC; Nair SC; Gupta MK; Uppin MS; Challa S; Puligopu AK; Ankathi P; Purohit AK; Chandak GR; Pandey A; Sirdeshmukh R
Mol Cell Proteomics; 2012 Jun; 11(6):M111.013565. PubMed ID: 22219345
[TBL] [Abstract][Full Text] [Related]
7. Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling.
Wells A; Souto JC; Solava J; Kassis J; Bailey KJ; Turner T
Clin Cancer Res; 2002 Apr; 8(4):1251-7. PubMed ID: 11948140
[TBL] [Abstract][Full Text] [Related]
8. Biology of the gonadotropin-releasing hormone system in gynecological cancers.
Gründker C; Günthert AR; Westphalen S; Emons G
Eur J Endocrinol; 2002 Jan; 146(1):1-14. PubMed ID: 11751060
[TBL] [Abstract][Full Text] [Related]
9. In search of the molecular mechanisms mediating the inhibitory effect of the GnRH antagonist degarelix on human prostate cell growth.
Sakai M; Martinez-Arguelles DB; Patterson NH; Chaurand P; Papadopoulos V
PLoS One; 2015; 10(3):e0120670. PubMed ID: 25811175
[TBL] [Abstract][Full Text] [Related]
10. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN].
Zhao LJ; Wei LH; Li XP; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):45-9. PubMed ID: 19563062
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
[TBL] [Abstract][Full Text] [Related]
12. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
[TBL] [Abstract][Full Text] [Related]
13. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
14. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
[TBL] [Abstract][Full Text] [Related]
15. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
17. Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF-κB survival signatures following GNRH receptor activation.
Meyer C; Sims AH; Morgan K; Harrison B; Muir M; Bai J; Faratian D; Millar RP; Langdon SP
Endocr Relat Cancer; 2013 Feb; 20(1):123-36. PubMed ID: 23202794
[TBL] [Abstract][Full Text] [Related]
18. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer.
Gründker C; Emons G
Reprod Biol Endocrinol; 2003 Oct; 1():65. PubMed ID: 14594454
[TBL] [Abstract][Full Text] [Related]
19. Leuprorelin acetate long-lasting effects on GnRH receptors of prostate cancer cells: an atomic force microscopy study of agonist/receptor interaction.
Lama G; Papi M; Angelucci C; Maulucci G; Sica G; De Spirito M
PLoS One; 2013; 8(1):e52530. PubMed ID: 23326338
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomic analysis of global effect of LLL12 on U87 cell's proteome: An insight into the molecular mechanism of LLL12.
Jain R; Kulkarni P; Dhali S; Rapole S; Srivastava S
J Proteomics; 2015 Jan; 113():127-42. PubMed ID: 25286751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
